Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution in Adult Participants With Respiratory Syncytial Virus Infection

NCT07808268 is registered in ClinicalTrials.gov with Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT07808268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07808268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of YKYY018 for Inhalation Solution in Adult Participants With Respiratory Syncytial Virus Infection
Lead sponsor
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 10, 2026
Completion date
March 10, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv)